BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12859999)

  • 21. Identification of false-positive CBFbeta/MYH11 RT-PCR results.
    Hackwell SM; Robinson DO; Harvey JF; Ross FM
    Leukemia; 1999 Oct; 13(10):1617-9. PubMed ID: 10516764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.
    Kanagal-Shamanna R; Zhao W; Vadhan-Raj S; Nguyen MH; Fernandez MH; Medeiros LJ; Bueso-Ramos CE
    Int J Environ Res Public Health; 2012 Aug; 9(8):2788-800. PubMed ID: 23066397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gain of multiple copies of the CBFB gene: a new genetic aberration in a case of granulocytic sarcoma.
    Mallo M; Espinet B; Salido M; Ferrer A; Pedro C; Besses C; Pérez-Vila E; Serrano S; Florensa L; Solé F
    Cancer Genet Cytogenet; 2007 Nov; 179(1):62-5. PubMed ID: 17981216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
    Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
    J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
    Zhang XH; Zhang R; Li Y
    Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
    Martinelli G; Rondoni M; Buonamici S; Ottaviani E; Piccaluga PP; Malagola M; Baccarani M
    Haematologica; 2004 Apr; 89(4):495-7. PubMed ID: 15075086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
    Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
    Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
    Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
    Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
    Dissing M; Le Beau MM; Pedersen-Bjergaard J
    J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of CBF beta-MYH11 fusion transcript and inv(16)(p13;q22) in acute myelomonocytic leukemia(M4) by RT-PCR and FISH].
    He K; Gu B; Cao Q
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):23-6. PubMed ID: 10921098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.
    van der Reijden BA; Simons A; Luiten E; van der Poel SC; Hogenbirk PE; Tönnissen E; Valk PJ; Löwenberg B; De Greef GE; Breuning MH; Jansen JH
    Br J Haematol; 2002 Aug; 118(2):411-8. PubMed ID: 12139724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression.
    Xiaosu Z; Leqing C; Yazhen Q; Yu W; Xiaohui Z; Lanping X; Xiaojun H; Yingjun C
    Ann Hematol; 2019 Jan; 98(1):73-81. PubMed ID: 30159599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocation.
    Sekiguchi N; Watanabe T; Kobayashi Y; Inokuchi C; Kim SW; Yokota Y; Tanimoto K; Matsuno Y; Tobinai K
    Int J Hematol; 2005 Oct; 82(3):210-4. PubMed ID: 16207593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party.
    Langabeer SE; Walker H; Gale RE; Wheatley K; Burnett AK; Goldstone AH; Linch DC
    Br J Haematol; 1997 Mar; 96(4):736-9. PubMed ID: 9074414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
    Krauter J; Hoellge W; Wattjes MP; Nagel S; Heidenreich O; Bunjes D; Ganser A; Heil G
    Genes Chromosomes Cancer; 2001 Apr; 30(4):342-8. PubMed ID: 11241787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.
    Au WY; Lie AK; Lee CK; Liang R; Kwong YL
    Bone Marrow Transplant; 1999 Jun; 23(11):1201-3. PubMed ID: 10382962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
    Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
    Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique structural abnormality of chromosome 16 resulting in a CBF beta-MYH11 fusion transcript in a patient with acute myeloid leukemia, FAB M4.
    O'Reilly J; Chipper L; Springall F; Herrmann R
    Cancer Genet Cytogenet; 2000 Aug; 121(1):52-5. PubMed ID: 10958941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong.
    Chan NP; Wong WS; Ng MH; Tsang KS; Lau TT; Leung Y; Chik KW; Shing MM; Li CK
    Am J Hematol; 2004 Jul; 76(3):300-3. PubMed ID: 15224374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.